The European Commission has granted a conditional marketing authorization (CMA) for the Pfizer/BioNTech vaccine, making it the first Covid-19 vaccine authorized in the European Union.
Ursula von der Leyen, president of the European Commission, called it “an important chapter” in the EU’s fight against Covid-19.
The authorization comes after the European Medicines Agency (EMA) granted the Pfizer/BioNTech vaccine a conditional marketing authorization, greenlighting the drug for distribution, earlier on Monday.
Von der Leyen said at a press briefing on Monday: “The European medicines agency assessed this vaccine thoroughly, and it concluded that it is safe and effective against Covid-19.”
“As we have promised, this vaccine will be available for all EU countries, at the same time, on the same conditions,” she added. “The first batches of this vaccine will be shipped from Pfizer’s manufacturing site here in Belgium within the next days. I've always said during this pandemic that we are in this together. So vaccination can start at the same time, during the European Union vaccination days on December 27th 28th and 29th."
“This is our first vaccine, more will be approved soon if they prove to be safe and effective. EMA will issue its opinion on the second vaccine, that of Moderna on the 6th of January," she said.